首页> 外文OA文献 >Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study

【2h】

Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study

机译：Pasireotide长效释放在肢端肥大症中的安全性和耐受性-肢端肥大症，开放标签，多中心安全监测计划的结果，用于治疗需要接受药物治疗（ACCESS）研究的患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Maria Fleseriu; null null; Elisha Rusch; Eliza B. Geer;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Safety and tolerability of pasireotide long-acting release in acromegaly-results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study [J] . Fleseriu Maria, Rusch Elisha, Geer Eliza B. Endocrine. . 2017,第1期

机译：患者患者治疗患者患者的骨质疗化长效释放的安全性和可耐受性 - 治疗需要接受医疗治疗的患者（访问）研究
2. Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 study [J] . Shigeyuki Tahara, Mami Murakami, Tomomi Kaneko, Endocrine journal . 2017,第7期

机译：长效帕瑞肽在日本肢端肥大或垂体巨大患者中的疗效和安全性：多中心，开放标签，随机，2期研究的结果
3. Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: Results from a randomized, multicenter, open-label, phase i study [J] . WolinE.M., HuK., HughesG., Cancer chemotherapy and pharmacology. . 2013,第2期

机译：Pasireotide（SOM230）长效释放（LAR）制剂在胃肠道胰腺神经内分泌肿瘤患者中的安全性，耐受性，药代动力学和药效学：一项来自随机，多中心，开放标签，I期研究的结果
4. An open-label, multicenter, randomized,comparative, safety, efficacy, cycle control,and quality of life study of CTR 25, Alesse ,and Ortho Tri-Cyclen [C] . Victoria Davis, Brian Hauck, Sheila Dunn, World Congress on Fertility and Sterility . 2004

机译：开放标签，多中心，随机，比较，安全，疗效，循环控制和CTR 25，Alesse和Ortho Tri-Cyclen的生命研究
5. Efficacy and safety of novel collagen conduits filled with collagen filaments to treat patients with peripheral nerve injury: A multicenter, controlled, open-label clinical trial [D] . Saeki Masaomi, 佐伯将臣 2019

机译：充满胶原细丝的新型胶原蛋白导管治疗周围神经损伤患者的疗效和安全性：一项多中心，对照，开放标签的临床试验
6. Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly open-label multicenter safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study [O] . Maria Fleseriu, Elisha Rusch, Eliza B. Geer -1

机译：Pasireotide长效释放在肢端肥大症中的安全性和耐受性-肢端肥大症开放标签多中心安全监测计划的结果用于治疗需要接受药物治疗（ACCESS）研究的患者
7. Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic neuroendocrine tumors: results from a randomized, multicenter, open-label, phase I study [O] . Edward M. Wolin, Ke Hu, Gareth Hughes, 2013

机译：Pasireotide（SOM230）长效释放（LAR）制剂在胃肠道胰腺神经内分泌肿瘤患者中的安全性，耐受性，药代动力学和药效学：一项来自随机，多中心，开放标签，I期研究的结果

Safety and tolerability of pasireotide long-acting release in acromegaly—results from the acromegaly, open-label, multicenter, safety monitoring program for treating patients who have a need to receive medical therapy (ACCESS) study

著录项

引文网络

相似文献

相关主题

期刊订阅